SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-003911
Filing Date
2021-11-10
Accepted
2021-11-10 07:21:39
Documents
76
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q kymr-20210930.htm   iXBRL 10-Q 3819015
2 EX-31.1 kymr-ex31_1.htm EX-31.1 18756
3 EX-31.2 kymr-ex31_2.htm EX-31.2 18588
4 EX-32.1 kymr-ex32_1.htm EX-32.1 11291
5 EX-32.2 kymr-ex32_2.htm EX-32.2 11122
  Complete submission text file 0000950170-21-003911.txt   11611862

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kymr-20210930_lab.xml EX-101.LAB 535947
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT kymr-20210930_def.xml EX-101.DEF 243898
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT kymr-20210930_cal.xml EX-101.CAL 58459
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kymr-20210930.xsd EX-101.SCH 65315
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kymr-20210930_pre.xml EX-101.PRE 387665
11 EXTRACTED XBRL INSTANCE DOCUMENT kymr-20210930_htm.xml XML 2169656
Mailing Address 200 ARSENAL YARDS BLVD., SUITE 230 WATERTOWN MA 02472
Business Address 200 ARSENAL YARDS BLVD., SUITE 230 WATERTOWN MA 02472 857-285-5314
Kymera Therapeutics, Inc. (Filer) CIK: 0001815442 (see all company filings)

IRS No.: 812992166 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39460 | Film No.: 211394394
SIC: 2836 Biological Products, (No Diagnostic Substances)